10902 | HSAP00P0000125081 | 1.005 | 4.696 | 4.187 | 0.0007163 | 0.0289 | -0.3633 | BRD8 | bromodomain containing 8 | ENSG00000112983 | 602848 | 10902 | NM_139199 |
1869 | HSAP00P0000398637 | -1.375 | 9.004 | -4.543 | 0.0003432 | 0.01991 | 0.3402 | E2F1 | E2F transcription factor 1 | ENSG00000101412 | 189971 | 1869 | BC050369 |
1870 | HSAP00P0000007182 | -1.01 | 6.656 | -3.653 | 0.002185 | 0.05119 | -1.427 | E2F2 | E2F transcription factor 2 | ENSG00000007968 | 600426 | 1870 | BC007609 |
23741 | HSAP00P0000304322 | -1.232 | 9.27 | -4.922 | 0.000159 | 0.01356 | 1.076 | EID1 | EP300 interacting inhibitor of differentiation 1 | ENSG00000255302 | 605894 | 23741 | AF274947 |
54796 | HSAP00P0000192665 | -0.7507 | 5.367 | -2.114 | 0.05083 | 0.2517 | -4.344 | BNC2 | basonuclin 2 | ENSG00000173068 | 608669 | 54796 | NM_017637 |
5925 | HSAP00P0000280585 | -0.7279 | 7.01 | -2.904 | 0.01046 | 0.1132 | -2.903 | RB1 | retinoblastoma 1 | ENSG00000139687 | 109800, 180200, 182280, 259500, 614041 | 5925 | BC040540 |
5934 | HSAP00P0000324890 | -1.124 | 7.824 | -4.696 | 0.0002511 | 0.01693 | 0.6389 | RBL2 | retinoblastoma-like 2 (p130) | ENSG00000103479 | 180203 | 5934 | NM_005611 |
6046 | HSAP00P0000140484 | -0.8142 | 9.892 | -4.434 | 0.0004299 | 0.02242 | 0.1248 | BRD2 | bromodomain containing 2 | ENSG00000234507, ENSG00000204256, ENSG00000215077, ENSG00000236227, ENSG00000234704, ENSG00000230678, ENSG00000235307 | 601540 | 6046 | NM_005104 |
632 | HSAP00P0000029739 | -1.467 | 6.516 | -8.199 | 4.423e-07 | 0.0005869 | 6.591 | BGLAP | bone gamma-carboxyglutamate (gla) protein | ENSG00000242252 | 112260 | 632 | NM_199173 |
7704 | HSAP00P0000250049 | -1.915 | 8.458 | -6.358 | 1.012e-05 | 0.003107 | 3.693 | ZBTB16 | zinc finger and BTB domain containing 16 | ENSG00000109906 | 176797, 612447 | 7704 | NM_006006 |